BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9377190)

  • 1. Reactivation of oral herpes simplex virus: implications for clinical management of herpes simplex virus recurrence during radiotherapy.
    Oakley C; Epstein JB; Sherlock CH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Sep; 84(3):272-8. PubMed ID: 9377190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy.
    Epstein JB; Gorsky M; Hancock P; Peters N; Sherlock CH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):712-6. PubMed ID: 12464896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent herpes labialis: current treatment perspectives.
    Sciubba JJ
    Compend Contin Educ Dent; 2002 Jul; 23(7 Suppl 2):9-12. PubMed ID: 12789981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus: clinical presentation and treatment.
    Ryan WA
    Dent Today; 2001 May; 20(5):64-7. PubMed ID: 11443814
    [No Abstract]   [Full Text] [Related]  

  • 6. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
    Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
    J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.
    Asbell PA
    Trans Am Ophthalmol Soc; 2000; 98():285-303. PubMed ID: 11190029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
    O'Brien JJ; Campoli-Richards DM
    Drugs; 1989 Mar; 37(3):233-309. PubMed ID: 2653790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late relapse of herpes simplex virus encephalitis in a child due to reactivation of latent virus: clinicopathological report and review.
    Spiegel R; Miron D; Yodko H; Lumelsky D; Habib A; Horovitz Y
    J Child Neurol; 2008 Mar; 23(3):344-8. PubMed ID: 18230840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash.
    Nicolatou-Galitis O; Dardoufas K; Markoulatos P; Sotiropoulou-Lontou A; Kyprianou K; Kolitsi G; Pissakas G; Skarleas C; Kouloulias V; Papanicolaou V; Legakis NJ; Velegraki A
    J Oral Pathol Med; 2001 Sep; 30(8):471-80. PubMed ID: 11545238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous herpes simplex virus lesions induced by ultraviolet radiation. A review of model systems and prophylactic therapy with oral acyclovir.
    Spruance SL
    Am J Med; 1988 Aug; 85(2A):43-5. PubMed ID: 2841857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex type-1 virus infection.
    Huber MA
    Quintessence Int; 2003 Jun; 34(6):453-67. PubMed ID: 12859090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpesviridae-associated persistent mucocutaneous ulcers in acquired immunodeficiency syndrome. A clinicopathologic study.
    Flaitz CM; Nichols CM; Hicks MJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Apr; 81(4):433-41. PubMed ID: 8705589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
    Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent oral herpes simplex virus infection presenting as a tongue mass.
    Tabaee A; Saltman B; Shutter J; Hibshoosh H; Markowitz A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Mar; 97(3):376-80. PubMed ID: 15024363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model.
    Perna JJ; Mannix ML; Rooney JF; Notkins AL; Straus SE
    J Am Acad Dermatol; 1987 Sep; 17(3):473-8. PubMed ID: 2821086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIH Conference. Herpes simplex virus infection: biology, treatment, and prevention.
    Straus SE; Rooney JF; Sever JL; Seidlin M; Nusinoff-Lehrman S; Cremer K
    Ann Intern Med; 1985 Sep; 103(3):404-19. PubMed ID: 2411179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex: evolving concepts.
    Pereira FA
    J Am Acad Dermatol; 1996 Oct; 35(4):503-20; quiz 521-2. PubMed ID: 8859276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants.
    Redding SW; Montgomery MT
    Oral Surg Oral Med Oral Pathol; 1989 Jun; 67(6):680-3. PubMed ID: 2544843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovir.
    Rooney JF; Straus SE; Mannix ML; Wohlenberg CR; Banks S; Jagannath S; Brauer JE; Notkins AL
    J Infect Dis; 1992 Sep; 166(3):500-6. PubMed ID: 1323616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.